MBD2 and cancer: Concerning this study, we have recently identified the MBD2-p66α molecular system in Mi-2/NuRD CRC as a promising target for EMT modulation by observing the induction of MET (conversed process of EMT) by knockdown of MBD2 and/or p66α in cancer cells.